Please assess the completion status of the following clinical trial:

Trial Title: Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Bladder pain / suprapubic pressure or discomfort for \>6months~* Urgency/urgency incontinence and/or frequency for \>6months~* Written informed consent (including confirmation that the partner will also be treated and that during the treatment period sexual intercourse is only allowed using condoms)~Exclusion Criteria~* age \< 18 years~* Tetracycline allergy~* Intake of a tetracycline in the last 3 months~* pregnancy~* breast feeding~* bacterial cystitis in the last 4 weeks~* urethral/vaginal/cervical/uterine and/or rectal cancer~* chemical cystitis~* tuberculous cystitis~* benign or malignant bladder tumors~* Lack of radiologic exclusion of pelvic pathology

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- doxycycline (Type: ACTIVE_COMPARATOR): Zadorin-100® (doxycycline), licence number Swissmedic: 43051 Legal holder: Mepha Pharma AG, Aesch/BL
- placebo (Type: PLACEBO_COMPARATOR): Placebo Galepharm Composition: lactose monohydrate, ceolus PH 102, croscarmellose sodium, magnesiumstearat, manufacturer: Pharmacy Hotz, 8700 Küsnacht, Switzerland

Based on this trial design, predict the completion outcome and termination type (if applicable).